| Literature DB >> 25811353 |
Ryan M Williams1, Janki Shah1, Brandon D Ng1, Denise R Minton2, Lorraine J Gudas3, Christopher Y Park1,4, Daniel A Heller1,3.
Abstract
We synthesized "mesoscale" nanoparticles, approximately 400 nm in diameter, which unexpectedly localized selectively in renal proximal tubules and up to 7 times more efficiently in the kidney than other organs. Although nanoparticles typically localize in the liver and spleen, modulating their size and opsonization potential allowed for stable targeting of the kidneys through a new proposed uptake mechanism. Applying this kidney targeting strategy, we anticipate use in the treatment of renal disease and the study of renal physiology.Entities:
Keywords: Nanotechnology; cancer; controlled release; nanomedicine; targeted drug delivery
Mesh:
Substances:
Year: 2015 PMID: 25811353 PMCID: PMC4518714 DOI: 10.1021/nl504610d
Source DB: PubMed Journal: Nano Lett ISSN: 1530-6984 Impact factor: 11.189